Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience

Restricted access

OBJECTIVE

Patients with metastatic thyroid cancer have prolonged survival compared to those with other primary tumors. The spine is the most common site of osseous involvement in cases of metastatic thyroid cancer. As a result, obtaining durable local control (LC) in the spine is crucial. This study aimed to evaluate the efficacy of spine stereotactic radiosurgery (SSRS) in patients with metastatic thyroid cancer.

METHODS

Information on patients with metastatic thyroid cancer treated with SSRS for spinal metastases was retrospectively evaluated. SSRS was delivered with a simultaneous integrated boost technique using single- or multiple-fraction treatments. LC, defined as stable or reduced disease volume, was evaluated by examining posttreatment MRI, CT, and PET studies.

RESULTS

A total of 133 lesions were treated in 67 patients. The median follow-up duration was 31 months. Dose regimens for SSRS included 18 Gy in 1 fraction, 27 Gy in 3 fractions, and 30 Gy in 5 fractions. The histology distribution was 36% follicular, 33% papillary, 15% medullary, 13% Hurthle cell, and 3% anaplastic. The 1-, 2-, and 5-year LC rates were 96%, 89%, and 82%, respectively. The median overall survival (OS) was 43 months, with 1-, 2-, and 5-year survival rates of 86%, 74%, and 44%, respectively. There was no correlation between the absolute biological equivalent dose (BED) and OS or LC. Patients with effective LC had a trend toward improved OS when compared to patients who had local failure: 68 versus 28 months (p = 0.07). In terms of toxicity, 5 vertebral compression fractures (2.8%) occurred, and only 1 case (0.6%) of greater than or equal to grade 3 toxicity (esophageal stenosis) was reported.

CONCLUSIONS

SSRS is a safe and effective treatment option with excellent LC and minimal toxicity for patients with metastatic thyroid cancer. No association with increased radiation dose or BED was found, suggesting that such patients can be effectively treated with reduced dose regimens.

ABBREVIATIONS BED = biological equivalent dose; CTCAE = Common Terminology Criteria for Adverse Events; CTV = clinical target volume; GTV = gross tumor volume; LC = local control; OS = overall survival; RT = radiation therapy; SSRS = spine stereotactic radiosurgery; TKI = tyrosine kinase inhibitor.
Article Information

Contributor Notes

Correspondence David Boyce-Fappiano: MD Anderson Cancer Center, Houston, TX. drboyce@mdanderson.org.INCLUDE WHEN CITING Published online February 14, 2020; DOI: 10.3171/2019.12.SPINE191269.Disclosures Dr. Rhines is a consultant for Stryker and Globus.
Headings
References
  • 1

    Amdur RJBennett JOlivier KWallace AMorris CGLiu C: A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32:5155202009

    • Search Google Scholar
    • Export Citation
  • 2

    American Cancer Society: Key statistics for thyroid cancer. Atlanta: ACS (https://www.cancer.org/cancer/thyroid-cancer/about/key-statistics.html) [Accessed December 20 2019]

    • Search Google Scholar
    • Export Citation
  • 3

    Balagamwala EHMiller JAReddy CAAngelov LSuh JHTariq MB: Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery. J Neurooncol 137:2892932018

    • Search Google Scholar
    • Export Citation
  • 4

    Bernstein MBChang ELAmini BPan HCabanillas MWang XA: Spine stereotactic radiosurgery for patients with metastatic thyroid cancer: secondary analysis of phase I/II trials. Thyroid 26:126912752016

    • Search Google Scholar
    • Export Citation
  • 5

    Bishop AJTao RGuadagnolo BAAllen PKRebueno NCWang XA: Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine 27:3033112017

    • Search Google Scholar
    • Export Citation
  • 6

    Bishop AJTao RRebueno NCChristensen ENAllen PKWang XA: Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence. Int J Radiat Oncol Biol Phys 92:101610262015

    • Search Google Scholar
    • Export Citation
  • 7

    Boyce-Fappiano DElibe ESchultz LRyu SSiddiqui MSChetty I: Analysis of the factors contributing to vertebral compression fractures after spine stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 97:2362452017

    • Search Google Scholar
    • Export Citation
  • 8

    Cabanillas MEWaguespack SGBronstein YWilliams MDFeng LHernandez M: Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab 95:258825952010

    • Search Google Scholar
    • Export Citation
  • 9

    Chang ELShiu ASLii MFRhines LDMendel EMahajan A: Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys 59:128812942004

    • Search Google Scholar
    • Export Citation
  • 10

    Chang ELShiu ASMendel EMathews LAMahajan AAllen PK: Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7:1511602007

    • Search Google Scholar
    • Export Citation
  • 11

    Chiang AZeng LZhang LLochray FKorol RLoblaw A: Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys 86:6386422013

    • Search Google Scholar
    • Export Citation
  • 12

    Choksi PPapaleontiou MGuo CWorden FBanerjee MHaymart M: Skeletal complications and mortality in thyroid cancer: a population-based study. J Clin Endocrinol Metab 102:125412602017

    • Search Google Scholar
    • Export Citation
  • 13

    Chung CDawson LAJoshua AMBrade AM: Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib. Anticancer Drugs 21:2062092010

    • Search Google Scholar
    • Export Citation
  • 14

    Cox BWJackson AHunt MBilsky MYamada Y: Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e661e6672012

    • Search Google Scholar
    • Export Citation
  • 15

    Cox BWSpratt DELovelock MBilsky MHLis ERyu S: International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 83:e597e6052012

    • Search Google Scholar
    • Export Citation
  • 16

    Demura SKawahara NMurakami HAbdel-Wanis MEKato SYoshioka K: Total en bloc spondylectomy for spinal metastases in thyroid carcinoma. J Neurosurg Spine 14:1721762011

    • Search Google Scholar
    • Export Citation
  • 17

    Elibe EBoyce-Fappiano DRyu SSiddiqui MSWen NLee I: Stereotactic radiosurgery for multiple myeloma of the spine. J Radiat Oncol 7:37442018

    • Search Google Scholar
    • Export Citation
  • 18

    Fine JPGray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:4965091999

  • 19

    Folkert MRBilsky MHTom AKOh JHAlektiar KMLaufer I: Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys 88:108510912014

    • Search Google Scholar
    • Export Citation
  • 20

    Garg AKShiu ASYang JWang XSAllen PBrown BW: Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 118:506950772012

    • Search Google Scholar
    • Export Citation
  • 21

    Gerszten PCBurton SAOzhasoglu CWelch WC: Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32:1931992007

    • Search Google Scholar
    • Export Citation
  • 22

    Ghia AJChang ELBishop AJPan HYBoehling NSAmini B: Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine 24:8298362016

    • Search Google Scholar
    • Export Citation
  • 23

    Gomez DRBlumenschein GR JrLee JJHernandez MYe RCamidge DR: Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:167216822016

    • Search Google Scholar
    • Export Citation
  • 24

    Gomez DRHunt MAJackson AO’Meara WPBukanova ENZelefsky MJ: Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 93:4144182009

    • Search Google Scholar
    • Export Citation
  • 25

    Ho JCTang CDeegan BJAllen PKJonasch EAmini B: The use of spine stereotactic radiosurgery for oligometastatic disease. J Neurosurg Spine 25:2392472016

    • Search Google Scholar
    • Export Citation
  • 26

    Klekamp JSamii H: Surgical results for spinal metastases. Acta Neurochir (Wien) 140:9579671998

  • 27

    Kushchayeva YSKushchayev SVCarroll NMFelger EALinks TPTeytelboym OM: Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. Thyroid 24:148815002014

    • Search Google Scholar
    • Export Citation
  • 28

    Laufer IRubin DGLis ECox BWStubblefield MDYamada Y: The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18:7447512013

    • Search Google Scholar
    • Export Citation
  • 29

    Levine AMColeman CHorasek S: Stereotactic radiosurgery for the treatment of primary sarcomas and sarcoma metastases of the spine. Neurosurgery 64 (2 Suppl):A54A592009

    • Search Google Scholar
    • Export Citation
  • 30

    Mehta KKaubisch ATang JPirlamarla AKalnicki S: Radiation recall dermatitis in patients treated with sorafenib. Case Rep Oncol Med 2018:21710622018

    • Search Google Scholar
    • Export Citation
  • 31

    Muresan MMOlivier PLeclère JSirveaux FBrunaud LKlein M: Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 15:37492008

    • Search Google Scholar
    • Export Citation
  • 32

    Naoum GEMorkos MKim BArafat W: Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol Cancer 17:512018

  • 33

    Oh DPark HCLim HYYoo BC: Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction. Radiat Oncol J 31:1711742013

    • Search Google Scholar
    • Export Citation
  • 34

    Palma DAOlson RAHarrow SGaede SLouie AVHaasbeek C: Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): results of a randomized trial. Int J Radiat Oncol Biol Phys 102:S3S42018

    • Search Google Scholar
    • Export Citation
  • 35

    Pan HYAllen PKWang XSChang ELRhines LDTatsui CE: Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys 90:8708762014

    • Search Google Scholar
    • Export Citation
  • 36

    Redmond KJRobertson SLo SSSoltys SGRyu SMcNutt T: Consensus contouring guidelines for postoperative stereotactic body radiation therapy for metastatic solid tumor malignancies to the spine. Int J Radiat Oncol Biol Phys 97:64742017

    • Search Google Scholar
    • Export Citation
  • 37

    Sahgal ALarson DAChang EL: Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys 71:6526652008

    • Search Google Scholar
    • Export Citation
  • 38

    Sahgal AWeinberg VMa LChang EChao SMuacevic A: Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 85:3413472013

    • Search Google Scholar
    • Export Citation
  • 39

    Shiu ASChang ELYe JSLii MRhines LDMendel E: Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys 57:6056132003

    • Search Google Scholar
    • Export Citation
  • 40

    Surveillance Epidemiology and End Results Program (SEER): Cancer stat facts: thyroid cancer. Bethesda, MD: NCI (https://seer.cancer.gov/statfacts/html/thyro.html) [Accessed December 20 2019]

    • Search Google Scholar
    • Export Citation
  • 41

    Tang CHess KBishop AJPan HYChristensen ENYang JN: Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int J Radiat Oncol Biol Phys 93:1181252015

    • Search Google Scholar
    • Export Citation
  • 42

    van der Linden YMDijkstra SPDSVonk EJAMarijnen CAMLeer JWH: Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103:3203282005

    • Search Google Scholar
    • Export Citation
  • 43

    Yamada YBilsky MHLovelock DMVenkatraman ESToner SJohnson J: High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71:4844902008

    • Search Google Scholar
    • Export Citation
  • 44

    Zelefsky MJGreco CMotzer RMagsanoc JMPei XLovelock M: Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 82:174417482012

    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 133 133 133
Full Text Views 4 4 4
PDF Downloads 4 4 4
EPUB Downloads 0 0 0
PubMed
Google Scholar